PACS and RIS Market is Estimated to Witness High Growth Owing to Opportunity to Improve Workflow in Radiology Departments

PACS and RIS Market


 

Picture archiving and communication systems (PACS) and radiology information systems (RIS) are medical imaging software solutions that are used to securely store, analyze, and transfer digital images and reports electronically. PACS and RIS have numerous benefits over traditional film systems as they enable timely image access from multiple locations, reduce risk of lost or damaged films, allow integration of images with hospital information systems, and improve productivity by streamlining workflow in radiology departments.

The global PACS and RIS Market is estimated to be valued at US$ 3,657 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
The key opportunity for growth in the PACS and RIS market is to improve radiology workflow efficiency. Healthcare organizations are under increasing pressure to enhance productivity and reduce turnaround times for diagnostic imaging reports. PACS and RIS solutions can modernize and automate various workflow steps such as exam ordering, image acquisition, interpretation, and report distribution. This allows radiologists to spend more time on diagnostic activities rather than non-value added administrative tasks. Streamlined workflow using PACS and RIS can significantly improve department throughput and patient satisfaction. Vendors providing innovative solutions focused on workflow optimization are likely to witness increased demand.

Porter’s Analysis

Threat of new entrants: The market has high capital requirements for setup of infrastructure and R&D which poses barrier for new entrants. The presence of established players also discourages new competition due to established customer base and brand loyalty.

Bargaining power of buyers: Buyers have moderate bargaining power due to availability of alternatives and choice of multiple vendors. However, switching costs associated with training and change in workflow limits bargaining power.

Bargaining power of suppliers: The market has many component suppliers with no single supplier dominance, giving buyers option to switch with minimal impact. This gives buyers higher bargaining power over suppliers.

Threat of new substitutes: Alternatives players are emerging with new technologies like cloud and web based solutions. However, integration capabilities with existing hospital infrastructure keeps threat of substitution low currently.

Competitive rivalry: The market has global presence of vendors competing on capabilities, pricing and customization. Industry consolidation is high with vendors competing to offer comprehensive one stop solutions.

SWOT Analysis
Strength: Presence of comprehensive product portfolio meeting diverse clinical requirements. Strong footprint of international players with global sales and service network.

Weakness: High dependency on hospital capital budgets and investment cycles exposed to economic slowdowns. Require specialized training and administration affecting user adoption.

Opportunity: Emerging regions in Asia Pacific and Latin America presenting new growth avenues. Increasing digitization and use of analytics providing avenues for product enhancement.

Threats: Currency fluctuations and trade barriers affecting pricing and market access between countries. Surging healthcare costs and budget pressures acting as financial headwinds.

Key Takeaways


Global PACS And RIS Market Demand is expected to witness high growth during forecast period aided by increasing healthcare infrastructure across major markets.

Global PACS and RIS market is estimated to be valued at US$ 3657 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030.

The Asia Pacific region is witnessing fastest growth supported by rising medical tourism and government focus on digitization of healthcare system especially in China, India, Japan and South Korea. North America currently dominates the global PACS and RIS market attributed to advanced healthcare facilities and early technology adoption in the region. Majority of revenue is generated from US market due to presence of leading vendors and availability of favorable insurance and reimbursement scenario for diagnostic procedures.

Key players operating in the PACS and RIS market are Daihen Corporation, Yaskawa Motoman Robotics, Denso Corporation, Universal Robots, Epson America, Inc., Panasonic Corporation, Epson America, Inc., Nachi Robotic Systems, Inc., FANUC Ltd., Mitsubishi Electric Corporation, Kawasaki Heavy Industries Ltd., and KUKA Robotics Corporation. Leading players are focusing on new product launches and partnerships to expand regional presence and capture higher market share.

Comments

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Ginseng Market Outlook, Analysis and forecast up to 2028

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19